TY - JOUR
T1 - Self-Assembly Induced Photosensitization of Long-Tailed Heavy-Atom-Free BODIPY Derivatives for Photodynamic Therapy
AU - li, Jigai
AU - Du, Xianfa
AU - Zhou, Xin
AU - Yoon, Juyoung
N1 - Funding Information:
The animal experiments were approved by the Animal Ethical Committee of Medical College of Qingdao University (QDU‐AEC‐2022040). X.Z. acknowledges the Natural Science Foundation of China (NSFC 21762045 and 21911540466), Shandong Provincial Natural Science Foundation (ZR2019YQ12), China Postdoctoral Science Foundation (219M652306), and Taishan Scholar Project (tsqn201812049) for supporting this work. J.Y. acknowledges a grant from the National Research Foundation of Korea (NRF) grant funded by the Korea government (No. 2022R1A2C3005420).
Publisher Copyright:
© 2023 Wiley-VCH GmbH.
PY - 2023
Y1 - 2023
N2 - Type I photosensitizers (PSs) are a promising approach for photodynamic therapy (PDT) since they can generate radicals that are tolerant to hypoxia. Thus, the development of highly efficient type I PSs is essential. Self-assembly is a promising strategy for developing novel PSs with desirable properties. Here, a simple and effective approach is developed to create heavy-atom-free PSs for PDT by self-assembling long-tailed boron dipyrromethene dyes (BODIPYs). The resulting aggregates BY-I16 and BY-I18 can efficiently convert their excited energy to the triplet state, producing reactive oxygen species that are essential for PDT. Furthermore, the aggregation and PDT performance can be regulated by adjusting the length of the tailed alkyl chains. As proof of concept, the efficacy of these heavy-atom-free PSs both in vitro and in vivo under both normoxic and hypoxic conditions is demonstrated.
AB - Type I photosensitizers (PSs) are a promising approach for photodynamic therapy (PDT) since they can generate radicals that are tolerant to hypoxia. Thus, the development of highly efficient type I PSs is essential. Self-assembly is a promising strategy for developing novel PSs with desirable properties. Here, a simple and effective approach is developed to create heavy-atom-free PSs for PDT by self-assembling long-tailed boron dipyrromethene dyes (BODIPYs). The resulting aggregates BY-I16 and BY-I18 can efficiently convert their excited energy to the triplet state, producing reactive oxygen species that are essential for PDT. Furthermore, the aggregation and PDT performance can be regulated by adjusting the length of the tailed alkyl chains. As proof of concept, the efficacy of these heavy-atom-free PSs both in vitro and in vivo under both normoxic and hypoxic conditions is demonstrated.
KW - BODIPY
KW - heavy-atom-free BODIPY
KW - photodynamic therapy
KW - self-assembly
KW - type I photosensitizers
UR - http://www.scopus.com/inward/record.url?scp=85160331932&partnerID=8YFLogxK
U2 - 10.1002/adhm.202301022
DO - 10.1002/adhm.202301022
M3 - Article
C2 - 37209386
AN - SCOPUS:85160331932
SN - 2192-2640
JO - Advanced Healthcare Materials
JF - Advanced Healthcare Materials
ER -